929 related articles for article (PubMed ID: 19706786)
21. Inhibition of glucagon secretion.
Young A
Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
[TBL] [Abstract][Full Text] [Related]
22. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
23. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
24. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue.
Matsubara T; Mita A; Minami K; Hosooka T; Kitazawa S; Takahashi K; Tamori Y; Yokoi N; Watanabe M; Matsuo E; Nishimura O; Seino S
Cell Metab; 2012 Jan; 15(1):38-50. PubMed ID: 22225875
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
26. [Expression and pharmacological evaluation of fusion protein FGF21-L-Fc].
Yao WB; Ren GP; Han Y; Cao HW; Gao HM; Kan FM; Wang Q; Li DS
Yao Xue Xue Bao; 2011 Jul; 46(7):787-92. PubMed ID: 22010347
[TBL] [Abstract][Full Text] [Related]
27. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice.
Moriarty MW; McCurdy CE; Janssen RC; Shaw T; Leitner JW; Friedman JE; Draznin B
Horm Metab Res; 2009 Oct; 41(10):757-61. PubMed ID: 19598077
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
Berglund ED; Li CY; Bina HA; Lynes SE; Michael MD; Shanafelt AB; Kharitonenkov A; Wasserman DH
Endocrinology; 2009 Sep; 150(9):4084-93. PubMed ID: 19470704
[TBL] [Abstract][Full Text] [Related]
29. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue.
Moloney F; Toomey S; Noone E; Nugent A; Allan B; Loscher CE; Roche HM
Diabetes; 2007 Mar; 56(3):574-82. PubMed ID: 17327424
[TBL] [Abstract][Full Text] [Related]
30. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone.
Hoggard N; Cruickshank M; Moar KM; Barrett P; Bashir S; Miller JD
J Mol Endocrinol; 2009 Oct; 43(4):171-7. PubMed ID: 19491194
[TBL] [Abstract][Full Text] [Related]
31. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.
Muise ES; Azzolina B; Kuo DW; El-Sherbeini M; Tan Y; Yuan X; Mu J; Thompson JR; Berger JP; Wong KK
Mol Pharmacol; 2008 Aug; 74(2):403-12. PubMed ID: 18467542
[TBL] [Abstract][Full Text] [Related]
32. Acute exercise reduces insulin resistance-induced TRB3 expression and amelioration of the hepatic production of glucose in the liver of diabetic mice.
Lima AF; Ropelle ER; Pauli JR; Cintra DE; Frederico MJ; Pinho RA; Velloso LA; De Souza CT
J Cell Physiol; 2009 Oct; 221(1):92-7. PubMed ID: 19492410
[TBL] [Abstract][Full Text] [Related]
33. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
34. Development of a novel long-acting antidiabetic FGF21 mimetic by targeted conjugation to a scaffold antibody.
Huang J; Ishino T; Chen G; Rolzin P; Osothprarop TF; Retting K; Li L; Jin P; Matin MJ; Huyghe B; Talukdar S; Bradshaw CW; Palanki M; Violand BN; Woodnutt G; Lappe RW; Ogilvie K; Levin N
J Pharmacol Exp Ther; 2013 Aug; 346(2):270-80. PubMed ID: 23720456
[TBL] [Abstract][Full Text] [Related]
35. FGF21 Normalizes Plasma Glucose in Mouse Models of Type 1 Diabetes and Insulin Receptor Dysfunction.
Diener JL; Mowbray S; Huang WJ; Yowe D; Xu J; Caplan S; Misra A; Kapur A; Shapiro J; Ke X; Wu X; Bose A; Panza D; Chen M; Beaulieu V; Gao J
Endocrinology; 2021 Sep; 162(9):. PubMed ID: 33951176
[TBL] [Abstract][Full Text] [Related]
36. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
[TBL] [Abstract][Full Text] [Related]
37. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.
So WY; Cheng Q; Xu A; Lam KS; Leung PS
Cell Death Dis; 2015 Mar; 6(3):e1707. PubMed ID: 25811804
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action.
Krumm CS; Giesy SL; Caixeta LS; Perfield JW; Sauerwein H; Moore BL; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11586-11596. PubMed ID: 31548053
[TBL] [Abstract][Full Text] [Related]
39. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of 5-benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione derivatives for the treatment of obesity-related nonalcoholic fatty liver disease.
Ma L; Xie C; Ran Y; Liang X; Huang L; Pei H; Chen J; Liu J; Sang Y; Lai H; Peng A; Xiang M; Wei Y; Chen L
J Med Chem; 2012 Nov; 55(22):9958-72. PubMed ID: 23025244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
